Activery Biotech SL (Activery) was founded by Carles Ventosa in 2003 to use the particle design potential of emerging SCF ( Super Critical Fluids ) technologies to create modified and enhanced solid-states of active pharmaceutical ingredients.

Recently, Dr. Andreas Kordikowski (formerly in Nektar Therapeutics Ltd.), recognized expert in supercritical fluid crystallization joined the company as R&D director.